Usefulness of the Framingham Risk Score in Patients With Chronic Psoriasis
The American Journal of Cardiology, 12/03/2010

1 Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy Archives of Dermatology, April 23, 2012

2 Epigenetics and psoriasis Journal of the European Academy of Dermatology and Venereology, April 16, 2012

3 Tea Tree Oil as a Novel Antipsoriasis Weapon Skin Pharmacology and Applied Skin Physiology, April 5, 2012    Clinical Article

4 Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study British Journal of Dermatology, April 2, 2012

5 Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus Journal of the European Academy of Dermatology and Venereology, March 5, 2012    Clinical Article

6 Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis Journal of the European Academy of Dermatology and Venereology, April 10, 2012

7 Combination Treatments for Psoriasis Archives of Dermatology, April 19, 2012    Clinical Article

8 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Addition of Methotrexate to Etanercept in Patients with Moderate to Severe Plaque Psoriasis British Journal of Dermatology, April 30, 2012    Clinical Article

9 Disease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study Journal of the European Academy of Dermatology and Venereology, March 28, 2012

10 Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients British Journal of Dermatology, April 18, 2012

11 Acitretin in psoriasis treatment – recommended treatment regimens Advances in Dermatology and Allergology, April 30, 2012    Clinical Article

12 Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis British Journal of Dermatology, April 27, 2012    Clinical Article

13 Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: The role of schemas in chronic skin disease British Journal of Dermatology, April 26, 2012

14 Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol Skin Research and Technology, April 11, 2012    Clinical Article

15 Safety of treatment with biologics for psoriasis in daily practice: 5-year data Journal of the European Academy of Dermatology and Venereology, February 28, 2012

16 Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomised, placebo-controlled trial with a re-treatment extension British Journal of Dermatology, April 17, 2012    Clinical Article

17 German S3-guidelines on the treatment of psoriasis vulgaris Archives of Dermatological Research, February 22, 2012    Clinical Article

18 Antimicrobial peptides in the pathogenesis of psoriasis Journal of Dermatology, March 21, 2012    Clinical Article

19 Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque-type psoriasis International Journal of Dermatology, April 24, 2012    Clinical Article

20 Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting Archives of Dermatology, April 24, 2012    Clinical Article